# Anti-CD3 & Anti-CD7 Ricin A Immunotoxin-Combination for Acute Graft Versus Host Disease

> **NCT00640497** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **Henogen** · enrollment: 12 (estimated)

## Conditions studied

- Acute Graft Versus Host Disease

## Interventions

- **BIOLOGICAL:** IT-Combination

## Key facts

- **NCT ID:** NCT00640497
- **Lead sponsor:** Henogen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2010-01
- **Primary completion:** 2012-01
- **Final completion:** 2012-01
- **Target enrollment:** 12 (ESTIMATED)
- **Why stopped:** Unavailability of investigational product
- **Last updated:** 2009-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00640497

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00640497, "Anti-CD3 & Anti-CD7 Ricin A Immunotoxin-Combination for Acute Graft Versus Host Disease". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00640497. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*